Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. Amgen is once again fighting the biosimilar battle on all fronts. Thousand Oaks-based biotech giant Amgen punched a rival drug maker hard when the Food and Drug Administration recommended approval of an Amgen biosimilar but took a hit when the FDA recommended…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
